+381 64 251 88 20
+381 64 251 88 20

Arterijska hipertenzija

According to medical statistics, arterial hypertension, or elevated blood pressure, is the main cause of death all over the world along with cerebral atherosclerosis. EmCell offers fetal stem cell therapy in a combined treatment of arterial hypertension aimed at improving the condition of arterial walls and blood pressure stabilization.

At Cell Therapy Center EmCell, patients with primary arterial hypertension with frequent arterial crises receive transplantation of fetal stem cells of ectodermal and mesenchymal origin. Prior to transplantation, continuous hypotensive therapy regimen is selected; that allows for preventing hypertensive crises, and diastolic pressure stabilizes at the level no higher than 90 mm Hg.

Stem cell therapy has pronounced positive effects in treatment of arterial hypertension and results in:

  • vascular system improvement: stem cells begin to produce angiogenic and anti-inflammatory factors;
  • partial replacement of destroyed or damaged cells;
  • improved cerebral vessel functioning and cardiac blood supply;
  • increased elasticity and permeability of blood vessels;
  • improved delivery of oxygen and nutritional elements to all organs and tissues—brain, heart, liver, kidneys—due to better blood flow.

Within 3–5 months after fetal stem cell transplantation, all patients demonstrate stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%. 

All patients note positive treatment effects such as disappearance of headache, stabiliziation and normalization of blood pressure and sleep, improved mental ability and sexual potency (both in men and women), return of vivacity – signs of rejuvenation.


Fetal Stem Cells in Post-Stroke Cognitive Deficit. Poster session.

Request additional information

Naše priče

Our patents